Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
QuantRX Biomedical Corp. (QTXB) had Return on Tangible Equity of 9.85% for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
-- |
|
$-0.26M |
|
-- |
|
-- |
|
$0.04M |
|
$-0.04M |
|
$-0.22M |
|
$-0.26M |
|
$-0.26M |
|
$-0.26M |
|
$-0.26M |
|
$-0.26M |
|
$-0.26M |
|
$-0.04M |
|
$-0.04M |
|
78.70M |
|
78.70M |
|
$-0.01 |
|
$-0.01 |
|
| Balance Sheet Financials | |
$0.01M |
|
-- |
|
-- |
|
$0.01M |
|
$2.65M |
|
-- |
|
-- |
|
$2.65M |
|
$-2.70M |
|
$-2.64M |
|
$-2.64M |
|
78.70M |
|
| Cash Flow Statement Financials | |
$-0.05M |
|
-- |
|
-- |
|
$0.06M |
|
$0.01M |
|
$-0.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.59 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
9.62% |
|
|
Return on Tangible Equity |
9.85% |
-4370.45% |
|
9.85% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|